A01K 2217/00
Genetically modified animals
A01K2217/00 (Genetically modified animals) appears on 6,719 US grants and 10,784 published applications in this corpus.
Search patents in A01K- Granted patents
- 6,719
- Published applications
- 10,784
- Assignees
- 2,802
- Inventors
- 15,976
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 9 | 0 |
| 1993 | 10 | 0 |
| 1994 | 12 | 0 |
| 1995 | 20 | 0 |
| 1996 | 78 | 0 |
| 1997 | 131 | 0 |
| 1998 | 258 | 0 |
| 1999 | 285 | 0 |
| 2000 | 300 | 0 |
| 2001 | 315 | 63 |
| 2002 | 310 | 798 |
| 2003 | 310 | 1504 |
| 2004 | 293 | 832 |
| 2005 | 232 | 732 |
| 2006 | 348 | 600 |
| 2007 | 344 | 461 |
| 2008 | 316 | 416 |
| 2009 | 268 | 438 |
| 2010 | 280 | 391 |
| 2011 | 219 | 344 |
| 2012 | 206 | 271 |
| 2013 | 183 | 259 |
| 2014 | 161 | 254 |
| 2015 | 178 | 239 |
| 2016 | 136 | 272 |
| 2017 | 159 | 255 |
| 2018 | 165 | 256 |
| 2019 | 145 | 313 |
| 2020 | 157 | 331 |
| 2021 | 147 | 323 |
| 2022 | 137 | 344 |
| 2023 | 154 | 300 |
| 2024 | 151 | 319 |
| 2025 | 173 | 291 |
| 2026 | 122 | 178 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- A01K 2217/05Animals comprising random inserted nucleic acidsIndexing code4,879
- A01K 2217/07Animals genetically altered by homologous recombinationIndexing code2,752
- A01K 2217/20Animal model comprising regulated expression systemIndexing code516
- A01K 2217/15Animals comprising multiple alterations of the genome, by transgenesis or homologous recombinationIndexing code490
- A01K 2217/30Animal model comprising expression system for selective cell killingIndexing code77
- A01K 2217/03Animals modified by random mutagenesisIndexing code5
Recent patents
- Non-human animals having humanized Fc-gamma receptors29 Sep 2026US 12,745,761 B2Regeneron Pharmaceuticals, Inc.
- Genetically modified non-human animal with human or chimeric TFR122 Sep 2026US 12,740,550 B2Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
- Methods of treating rheumatoid arthritis using RNA-guided genome editing of HLA gene22 Sep 2026US 12,742,179 B2National Jewish Health
- Non-viral transgenesis15 Sep 2026US 12,735,719 B2The Regents of the University of California
- Rat models for CMT2A that develop a progressive neuropathy1 Sep 2026US 12,721,327 B2Charcot-Marie-Tooth Association
- Transgenic model of human cardiomyopathy8 Oct 2026US 2026/0305586 A1Stichting Genetische Hartspierziekte PLN
- Humanized ace2-expressing transgenic mouse susceptible to sars-cov-2 virus infection and method for producing same8 Oct 2026US 2026/0305587 A1Seoul National University R&Db Foundation
- Genetically Modified Non-Human Animals and Methods of Use Thereof8 Oct 2026US 2026/0305588 A1Institute for Research in Biomedicine (IRB)
- Mouse model with humanized telomere1 Oct 2026US 2026/0293864 A1Washington State Univesity
- Single-sex chicken with toxin-antitoxin system1 Oct 2026US 2026/0293865 A1New York University
Most cited
By later US patents
- Ransgenic non-human animals for producing heterologous antibodies1,941US 5,545,806 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies of various isotypes1,748US 5,569,825 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies1,680US 5,633,425 AGenPharm International, Inc. · 1997
- Transgenic non-human animals for producing heterologous antibodies1,604US 5,625,126 AGenPharm International, Inc. · 1997
- Production of antibodies from transgenic animals1,567US 5,545,807 AMedical Research Council · 1996